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Introduction
While production of reactive oxygen species (ROS) is a 
  consequence of basal cellular respiration, increased ROS pro-
duction is associated with several pathological conditions (i.e., 
hypoxia, ischemia) in many cellular systems.1 ROS can alter gene/
protein expression by acting as second messenger molecules that 
can influence intercellular signaling cascades, ultimately affect-
ing cell phenotype and function.2 Additionally, ROS can directly 
oxidize cellular components (i.e., lipids, DNA, proteins, mito-
chondrial components) leading to detrimental effects on the cell 
and contributing to disease progression. ROS have been ascribed 
as positive regulators of autophagy, a process of bulk degrada-
tion of organelles and proteins, in a multitude of cell systems, 
which may contribute to the ultimate fate of the cell, be it cell 
survival or death.3 This review highlights the roles of autophagy 
in response to ROS and increased conditions of oxidative stress 
and the relationship to several disease states (i.e., cancer, aging, 
neurological and vascular disorders).
Autophagy
Autophagy is a tightly regulated and evolutionary conserved 
process, and includes three main forms: chaperone-mediated 
autophagy (CMA), microautophagy and macroautophagy.4,5 CMA 
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has been described exclusively in mammals and   evolutionary 
data indicates it developed in response to the evolving needs 
of the species.6 CMA requires the complete unfolding of the 
autophagic materials prior to entry into lysosomes, and allows 
for individual proteins to be singled out and degraded.7 In con-
trast, both micro and macroautophagy sequester large amounts 
of cytosolic components for bulk degradation.8 Furthermore, 
microautophagy is characterized by the direct uptake of these 
cytosolic constituents through an invagination of the lysosomal 
membrane.9 This review focuses on macroautophagy (hereafter 
referred to as simply “autophagy”), which is a more common yet 
more complex mechanism for protein and organelle degradation 
in lysosomal vacuoles.10 During this catabolic process, long-lived 
organelles and cytoplasmic proteins are initially engulfed into 
polymembrane vesicles, known as phagophores. The edges of 
these phagophores expand in a process of vesicle elongation, and 
fuse to form the mature autophagosome.4,11 These autophago-
somes subsequently fuse with intercellular lysosomes, forming 
autophagolysosomes, inside of which the damaged sequestered 
material is degraded by lysosomal hydrolases.12,13
Regulation of Autophagosome Formation
The formation of the autophagosome in mammalian cells 
involves autophagy-related proteins (ATG), which are tightly 
regulated, most notably downstream of mammalian target of 
rapamycin (mTOR) Ser/Thr kinase.14 Autophagosome forma-
tion is inhibited when activated mTOR phosphorylates ATG13, 
preventing this protein from forming a complex with ATG1. 
This results in the inhibition of ATG1 kinase, which is essen-
tial for autophagic induction.4 During the autophagic-initiation 
step, dephosphorylation and inactivation of mTOR allows for 
the association of ATG13 and ATG1, thereby activating the 
ATG1 kinase activity and thus initiating autophagy (Fig. 1A).5 
Isolation membrane elongation involves two highly-conserved 
ubiquitin-like conjugation complexes in eukaryotes, including 
the ATG12-ATG5 complex, and the microtubule-associated 
protein 1 light chain 3 (yeast ATG8 mammalian homologue)—
phosphatidylethanolamine (LC3-PE).10,15,16 Facilitated by 
ATG7 and ATG10 enzymes, the ATG12-ATG5 conjugate 
binds ATG16 and this resulting complex is incorporated into 
the outer membrane of the isolation membrane and is essential 
for vesicle elongation (Fig. 1B).17 In the LC3-PE conjugation 
system, full length LC3 precursor is subjected to proteolytic 
Autophagy is a catalytic process of the bulk degradation of   
long-lived cellular components, ultimately resulting in lyso-
somal digestion within mature cytoplasmic compartments 
known as autophagolysosomes. Autophagy serves many 
functions in the cell, including maintaining cellular homeostasis, 
a means of cell survival during stress (e.g., nutrient deprivation 
or starvation) or conversely as a mechanism for cell death. 
increased reactive oxygen species (rOS) production and the 
resulting oxidative cell stress that occurs in many disease states 
has been shown to induce autophagy. The following review 
focuses on the roles that autophagy plays in response to the 
rOS generated in several diseases.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  169
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Oxidative Stress Induces Autophagy
Cellular oxidative stress and increased generation of ROS have 
been reported to serve as important stimuli of autophagy during 
periods of nutrient deprivation, ischemia/reperfusion, hypoxia, 
and in response to cell stress.3,24-26 The cysteine protease ATG4 
functions to cleave all homologues of ATG8 proximal to the 
C-terminus, priming ATG8 for subsequent conjugation to PE.27 
Like LC3-PE, lipidated ATG8 will incorporate into the autopha-
gosome membrane, which is necessary for autophagosome matu-
ration.28 However, ATG8-PE is also subjected to the proteolytic 
activity of ATG4, and therefore ATG4 can deconjugate ATG8 
from PE, resulting in autophagosome disassembly. Thus, inacti-
vation of ATG4 following the initial cleavage of ATG8 is needed 
to ensure the structural integrity of the mature autophagosome. 
During cellular starvation and nutrient deprivation, there is an 
increased generation of mitochondrial derived hydrogen per-
oxide (H2O2) through a PI3K/beclin-1 dependent pathway.3   
cleavage by the cystein protease ATG4, forming LC3-I.10 LC3-I 
is localized in the cytosol, and through the action of ubiq-
uitin-conjugating enzyme-like molecules ATG7 and ATG3, is 
conjugated to PE.12 LC3-PE (referred to as LC3-II), is then 
localized to the autophagosome membrane through the assis-
tance of ATG5 (Fig. 1B).18 Incidentally, the ratio of the pro-
tein expression of membrane associated LC3-II to cytosolic 
LC3-I (LC3II:I), is indicative of autophagosome formation, 
and therefore is often used to assess autophagic activity.19 
Additionally, cellular transfection of green-fluorescent protein-
(GFP)-LC3 allows for microscopic observation of autophagy 
by analyzing the amount of cells displaying GFP-LC3 puncta 
versus those cells displaying a more diffuse fluorescence.20,21 
Finally, lysosomal receptor proteins (Lamp-1 and Lamp-2) 
and the Rab GTPase Rab7 mediate the fusion of the mature   
autophagosomes with cytosolic lysosomes forming the 
autophagolysosome, and the sequestered components are 
hydrolyzed (Fig. 1C).22,23
Figure 1. Autophagosome formation. (A) induction: mTOr inhibition leads to downstream dephosphorylation of ATG13, allowing for its association 
with ATG1. This ATG13-ATG1 complex activates the kinase activity of ATG1. (B) elongation of the isolation membrane: ATG12-ATG5, facilitated by both 
ATG7 and ATG10, binds ATG16 and this resulting complex becomes incorporated into the outer membrane of the isolation membrane. in addition the 
full-length LC3 precursor is cleaved by ATG4, forming LC3-i, located in the cytosol. ATG7 and ATG3 (ubiquitin-conjugating enzyme-like molecules), aid 
in LC3-i conjugation to Pe, and this resulting complex (referred to as LC3-ii), is incorporated into to the autophagosome membrane aided by ATG5. (C) 
Autophagosome maturation: The mature autophagosomes fuse with cytosolic lysosomes and are mediated by lysosomal receptor proteins (Lamp-1, 
Lamp-2) and rab7. The resulting autophagolysosome is where cellular material and components are sequestered and hydrolyzed.170  Oxidative Medicine and Cellular Longevity  volume 3 issue 3
(i.e., organelles, cytosolic proteins) occur in nearly all cell types as 
a means to maintain cellular homeostasis.4 A robust enhancement 
of autophagy has been observed in developing mouse embryos, 
suggesting that this process plays an important role in develop-
ment and cell differentiation.3,4,43 Additionally, autophagy rapidly 
increases during periods of cellular starvation as a means to gen-
erate the necessary nutrients to sustain cell survival.44 However, 
excessive autophagy results in degradation of essential cell con-
stituents, ultimately resulting in a process referred to as type-II 
cell death.45 Determinants of whether autophagy promotes cell 
survival or cell death depend upon the severity and degree of 
stress in the cellular environment. Autophagic degradation and 
removal of damaged oxidized proteins in response to oxidative 
stress is reportedly beneficial for the cell.46,47 Conversely, severe 
oxidative stress and increasing amounts of ROS may activate sig-
naling pathways that lead to autophagic-induced cell death.48
Oxidative-Stress Induced Autophagy  
in Response to Disease
Many disease states are associated with elevated levels of ROS 
and increased oxidative stress and range from cardiovascular-
associated disorders such as heart failure and diabetes, to neu-
rodegenerative diseases, cystic fibrosis, rheumatoid arthritis and 
cancer.49-55 Elevated ROS causing autophagy promotes either 
This leads to oxidation and consequent inhibition of 
ATG4, ultimately promoting ATG8-PE conjugation 
and enhancing autophagy.3 Although ATG4 activity 
is regulated by the oxidative state of the local cellular 
environment, the question develops as to how ATG4 
is initially activated to allow for ATG8 lipidation, 
but then becomes inhibited to allow the lipidation of 
ATG8 to remain. Interestingly, the priming step of 
ATG8 (cleavage at the C-terminus) is not affected dur-
ing initial periods of nutrient deprivation, but rather 
it is the increased ROS generated over prolonged cel-
lular starvation that leads to oxidation and subsequent 
inhibition of ATG4 (Fig. 2).3
ROS induce autophagy through a beclin-1 depen-
dent pathway that is associated with autophagic 
induced cell-death.29 Beclin-1 is negatively regulated 
by its interaction with the anti-apoptotic protein Bcl-2 
under normal conditions.30 However, increased ROS 
activates the ubiquitin-proteosome system, which 
functions to degrade Bcl-2.31 This allows for beclin-1 
activation subsequently resulting in autophagic cell 
death.29 Additionally, oxidized low density lipopro-
teins may enhance autophagy by upregulating beclin-1 
gene expression.32 siRNA against beclin-1 attenuates 
ROS-mediated ganglioside induced autophagic cell 
death.33
Increased autophagy reportedly occurs with mito-
chondrial damage and/or failure of the mitochondria 
to generate adequate ATP levels (i.e., during cell star-
vation), thus implicating a key role for mitochondria 
in autophagy.34,35 Inhibition of the mitochondrial 
electron transport chain (mETC) results in increased ROS pro-
duction that is accompanied by cell death.36 Furthermore, inhi-
bition of mETC complex I and complex II with rotenone and 
trifluoroacetone respectively caused ROS-mediated autophagic-
induced cell death in transformed and cancer cell lines.37
Our laboratory among others has shown that aldosterone   
causes a generation in ROS in cultured adult rat ventricu-
lar myocytes.38 In vivo this leads to enhanced activity associ-
ated with cardiac remodeling including hypertrophy, increased 
matrix metalloproteinase activity, fibrosis, as well as apopto-
sis.39,40 Additionally, autophagic stimulation has been linked to 
pathologic conditions of cardiac remodeling in response to oxi-
dative stress, endoplasmic reticulum stress, and changes in the 
ubiqutin-proteosomal system.41,42 Previous unpublished data 
from our laboratory suggests that pathological levels of ROS 
induce autophagic mediated cardiomyocyte death through an 
ERK-MAPK-dependent pathway. Further exploration into the 
exact mechanism of autophagic mediated cardiomyocyte death 
in response to severe oxidative stress is needed.
Cellular Functions of Autophagy
Autophagy serves many functions in response to various   
stimuli throughout a multitude of cell systems. Basal levels 
of autophagic degradation of longed lived cell components   
Figure 2. rOS-mediated induction of autophagy. ATG4 primes ATG8 homologues for 
conjugation with Pe, allowing for lipidated ATG8 incorporation into the autophago-
some membrane. increased concentrations of rOS leads to oxidation and inactiva-
tion of ATG4 following the initial cleavage of ATG8, ensuring the structural integrity 
of the mature autophagosome, thereby promoting autophagy. The initial priming 
step of ATG8 is unaffected during the early phases of nutrient deprivation and rOS 
generation. However, over prolonged periods, the accumulating rOS generated will 
lead to oxidation and subsequent inhibition of ATG4.www.landesbioscience.com  Oxidative Medicine and Cellular Longevity  171
causes lipid peroxidation in the mitochondria, all of which 
exacerbate autophagy.67 Additionally, antioxidants such as cata-
lase and superoxide dismutase (SOD) are targeted by autopha-
gosomes, thereby increasing the presence of ROS and creating 
a positive autophagic feedback loop.13 This ultimately leads 
to the induction of cell death and is thus detrimental to cell 
function. Furthermore, AMPK activity decreases during reper-
fusion, thus increasing autophagic death and beclin-1 upregu-
lation.58,64,68-70 Ischemic preconditioning of the myocardium 
may be an effective method against lethal ischemic injury, and 
studies have indicated that autophagy is involved in cardiopro-
tection. Repetitive ischemia by coronary stenosis or coronary 
occlusion enhances autophagy and subsequent cardioprotec-
tion, compared to the classical I/R insult.71 Additionally, the 
antimicrobial agent sulfaphenazole, an inhibitor of cytochrome 
P4502C9, enhances autophagy in a PKC-dependent mecha-
nism in the adult rat cardiomyocyte.72 This exhibited the same 
cardioprotective results against I/R injury similar to that of the 
preconditioned heart.
I/R injury induce ROS generation and autophagic-mediated 
cell death in the renal vasculature. Hypoxia induces autophagic 
cell death in human renal proximal tubular epithelial HK-2 
cells, and autophagic inhibition prevented H2O2-induced cell 
death.73 Furthermore, overexpression of the anti-apoptotic 
protein Bcl-2 in mice prevented autophagosome formation in 
I/R-injured renal tubular cells.74 Others reported that adeno-
viral administration of Bcl-xl, a member of the Bcl-2 family, 
significantly reduced I/R-induced superoxide production and 
autophagy in the proximal and distal tubules of rat kidney.75   
As in the myocardium, periods of intermittent reperfusion 
cell survival or cell death, the fate of which depends upon the 
severity of the stress occurring with a particular disease. The 
following sections discuss the autophagic response to increased 
ROS in various disease states and pathologic conditions. Refer 
to Table 1 for a summary of the role of autophagy in these 
diseases.
(1) Autophagy in vascular disease. Autophagic activity may 
be rapidly increased in response to vascular stress that occurs 
during ischemic episodes. Autophagy was first reported in car-
diomyocytes by Sybers et al. in 1975, and occurs in response 
to acute coronary occlusion and myocardial infarction.42,56-60 
Once coronary artery flow is reestablished, it can be classi-
fied as an ischemia/reperfusion (I/R) injury. During the initial 
period of ischemia, formation of the enzyme xanthine oxidase 
(XO) occurs and hypoxanthine and xanthine, both substrates 
for XO, accumulate.61,62 Upon reperfusion, the reintroduction 
of molecular oxygen leads to XO-mediated superoxide radical 
(O2
-) generation due to the presence of xanthine and hypoxan-
thine.57 During the initial period of hypoxia, a modest induc-
tion of autophagy occurs, and pharmacological inhibition of 
autophagy with 3-methyladenine (3-MA) decreased cardio-
myocyte survival during ischemia, suggesting a cell survival 
role for autophagy during the initial ischemic insult.58,63 During 
this period, the resulting decrease in ATP generation results in 
the phosphorylation of AMP-activated protein kinase (AMPK), 
which leads to autophagosome formation through inhibition 
of mTOR.64,65 Ischemic insult also results in phosphorylation 
of heat shock protein (Hsp)20 at serine residue 16, leading to 
cardioprotection by enhancing autophagy.66 However, during 
reperfusion, ROS damages organelles, cytosolic proteins and 
Table 1. Autophagy and rOS in disease states
Disease Cell/system Function of autophagy Reference
Pathologic cardiac remodeling Cardiac tissue Oxidative stress-mediated autophagic cell death 41, 42
Heart failure Cardiomyocytes Pathologic levels of rOS-mediated autophagic cell death unpublished
Myocardial infarction/ischemia 
reperfusion (i/r) injury
Cardiomyocytes
Xanthine oxidase mediated rOS generation exacerbates 
autophagy and leads to death
42, 56–60
renal ischemia reperfusion 
injury
renal tubule epithelial cells
i/r-mediated rOS generation, increases autophagy and leads 
to cell death
74, 75
Stroke, neuronal ischemic 
injury
Neuronal cells
i/r-mediated rOS generation, increases autophagy and leads 
to cell death
76–78
Huntington disease, Alzheimer, 
Parkinson
Neuronal cells
rOS generation induces pro-survival autophagic removal of 
harmful protein aggregates
82–86
Alzheimer Neuronal cells
excessive rOS generation leading to mitochondrial 
  damage, increasing autophagic degradation of essential cell 
  constituents resulting in death
97
epilepsy Neuronal cells
rOS generation mediates cystatin C-induced autophagic 
clearance of harmful aggregates (i.e., stefin B)
87, 88
Aging Post-mitotic cells
impairment of lysosome/autophagosome fusion and loss of 
autophagic function during aging leads to accumulation of 
rOS and damaged cell material and cell death
4, 105, 106, 110
Cancer/Tumor formation
Prostate and colorectal cancer 
cells
reduced autophagic activity accompanied by rOS 
  accumulation, somatic mutations and cancer pathogenesis
63, 121, 122
Cancer/Tumor survival
Pre-exisiting tumors/multiple 
myeloma cells, cervix carcinoma
Cell starvation and rOS triggered autophagy promotes 
tumor survival in nutrient deprived environments
135, 137–139172  Oxidative Medicine and Cellular Longevity  volume 3 issue 3
induction of autophagy with the use of rapamycin analogues 
prevents neurodegeneration.90 Furthermore, studies utilizing 
small molecular enhancers of rapamycin induced autophagic 
degradation of mutant Huntington protein aggregates and 
protected against neurotoxicity in Huntington disease cell and 
Drosophila   models.91 Finally, overexpression of ATG8a gene 
in aged Drosophila brains promoted resistance to oxidative 
stress and prevented the build up of oxidized and ubiquitinated 
protein aggregates while extending lifespan.92 These findings 
suggest that pharmacologic modulators of autophagy may be 
applied as potential therapeutic interventions against neurode-
generative diseases.
In many cases, increased oxidative stress and ROS genera-
tion are observed in neurodegenerative disorders resulting in 
enhanced autophagic activity beyond basal levels.93 Under these 
conditions, autophagy is no longer considered a cell-survival 
mechanism, but promotes type-II programmed cell death. An 
increased number of autophagosomes are found in the brains of 
patients diagnosed with Alzheimer, Huntington and Parkinson 
diseases.86,90 Dopamine-toxicity inhibited mTOR, leading 
to an increase in LC3-II expression and cell loss in SH-SY5Y 
neuroblastoma cells.94,95 This was prevented with the antioxi-
dant N-acetylcysteine, suggesting that products of dopamine 
oxidation play a role in autophagic-induced neural cell degen-
eration. In Alzheimer disease, oxidative stress caused neuronal 
cell death by inducing autophagy of accumulated amyloid 
b-protein (Abeta) and subsequent permeabilization of the lyso-
somal membrane contributing to neuron death.96 Mitochondria 
damaged by oxidative stress in pyramidal neurons are sub-
jected to autophagic degradation in Alzheimer disease (termed 
mitophagy), eventually leading to neurodegeneration.97 Finally, 
aberrant expression of protein phosphatase 2A (PP2A) is associ-
ated with the onset of a number of neural degenerative disorders. 
It was recently reported that neuroblastoma cells transfected 
with PP2A constructs have an increased susceptibility to oxi-
dative stress mediated cell death, and inhibition of autophagy 
with siRNA against autophagic genes prevented this death.98
Another mechanism of oxidative stress induced autophagy 
in neural cells involves Oxi-α, a neuroprotective protein   
identified in dopamine neurons.99 Oxi-α is downregulated during 
oxidative stress, thus rendering neurons susceptible to oxida-
tive stress induced death. Under normal conditions, Oxi-α acti-
vates mTOR, and thus suppresses autophagosome formation. 
However, increased levels of ROS downregulates Oxi-α and 
leads to decreased mTOR activity, thereby increasing autopha-
gosome formation. Furthermore, inhibition of autophagy with 
3-MA protected against neuronal death under oxidative stress, 
confirming the involvement of autophagy in cell-death in   
neurodegenerative diseases.100
(3) Autophagy and aging. Basal levels of oxidative stress as 
a result of aerobic metabolism over a lifespan will lead to altera-
tions and damage to structures, eventually resulting in cell 
death.101 Lipofuscin and ceroid are related pigments that form 
in the presence of H2O2 and accumulate during aging in sec-
ondary lysosomes of post-mitotic cells.102,103 In both experimen-
tal and human models, there is an observed loss of autophagic 
during prolonged ischemia protects against renal dysfunction   
as compared to classical I/R injury, and this involved an increase 
in antioxidant defense mechanisms and suppression of oxidative 
stress and autophagy.24
Enhanced autophagy activity is seen in ischemic events 
  occurring in the cerebral vasculature. In the penumbra of 
rats exposed to cerebral ischemia there is increased beclin-1 
and LC3 protein expression observed along with DNA dam-
age in neuronal cells, suggesting cell death.76 Neonatal rats 
subjected to focal cerebral ischemia exhibited autophagosome 
specific LC3-II protein expression located in the periphery of 
neuronal lesions, indicating autophagic-mediated cell death.77 
Post-ischemic treatment with the autophagic inhibitor 3-MA 
reduced the size of these lesions. Others showed that ATG7-
deficiant neonatal mice subjected to ischemic episodes were 
completely protected from neuronal death, suggesting ATG7 
as a potential therapeutic target against neuronal cell death fol-
lowing ischemic brain injuries such as stroke.78 Repeated I/R in 
a rat spinal cord injury model resulted in enhanced immuno-
reactivity of LC3 and eventually neuronal death.79 Conversely, 
it has been suggested that activation of autophagy actually pro-
motes cell survival in the initial stages of ischemic brain injury.80 
Treatment with rapamycin, an autophagic inductor, increased 
beclin-1 expression, and lead to a reduction in cell death and 
neural injury in response to neonatal ischemic injury. Finally, 
ischemic-preconditioning lead to increased LC3-II expression 
in an in vitro PC12 cell model, and blockage of autophagy with 
3-MA decreased cell viability, indicating that autophagy plays a 
neuroprotective role in ischemic preconditioning.81
(2) Role of autophagy in neurodegenerative disease. Debate 
continues as to whether autophagy directly contributes to neu-
rodegenerative diseases or if it serves as a prosurvival response. 
Once again basal autophagy may lead to the clearance and deg-
radation of potentially harmful protein aggregates that are asso-
ciated with Huntington, Parkinson, and Alzheimer diseases,82-84 
therefore being important in the protective maintenance of neu-
ral cells.85 For instance, in a dopamine D (2) receptor knockout 
mouse model of Parkinson’s disease, increased oxidative stress 
and formation of alpha-synuclein aggregate is associated with 
increased autophagic activity.86 Confocal microscopy revealed 
colocalization of LC3 and stefin B aggregates, a protein linked 
with epileptic syndromes leading to neurodegeneration and 
increased oxidative stress.87 Cystatin C (CysC) is increased in 
the brain of animal models with neurodegenerative diseases and 
in human epileptic patients, and may have a neuroprotective 
role in response to oxidative stress. CysC enhances autophagic 
clearance of aggregates via a mTOR dependent pathway. 
Conversely beclin-1 siRNA or 3-MA inhibits the neuroprotec-
tive role of CysC.88 ATG5 knockdown and suppression of basal 
autophagy caused protein aggregate accumulation in mouse 
neural cells and was accompanied by impaired motor function. 
Similarly, suppression of ATG7 in the central nervous system of 
mice was accompanied by impaired motor function, behavioral 
defects, protein inclusion body accumulation, neurodegenera-
tion in both the cerebral and cerebellar cortices, and death.89   
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by autophagy may be due to prolonged oxidative stress induced-
autophagic cell death. H2O2 triggered autophagy-induced cell 
death in C6 glioma cells by BNIP3 inhibition of mTOR.124 ROS 
have been reported to induce autophagy in several cancer cell 
lines37,125-127 eventually resulting in cell death, while inhibition of 
autophagy with 3-MA or siRNA directed against ATGs inhibits 
this ROS-induced cell death.37 Allelic loss of beclin-1 is associated 
with human cancers that are susceptible to an accumulation of 
ROS and subsequent genomic damage and tumor growth.128
These findings give insight into the potential development of 
anti-cancer therapies that target autophagy for cancer prevention. 
For example, induction of oxidative stress by glucose oxidase or 
tert-butyl hydroperoxide induces autophagy and effectively sup-
presses tumor growth in a glioblastoma brain cancer model and 
HT-29 colon cancer cells respectively.37,129,130 Valproic acid, an 
anti-epileptic agent, was shown to also have tumor suppressing 
capabilities through an increase in ROS ERK1/2 dependent path-
way that causes glioma cell death by autophagy.131 Interestingly, 
∆9-tetrahydrocannabinol, the psychoactive compound found in 
marijuana, displays potential anti-tumor properties by induc-
ing endoplasmic reticulum (ER)-stress and downstream inhi-
bition of mTOR resulting in autophagic induced cell death.132 
Autophagy induced by caloric restriction may prevent cancer, as 
caloric restriction has been reported to double the lifespan and 
delay tumor formation in mice.133,134 Pharmacologic agonists of 
autophagic pathways such as inhibitors of mTOR (i.e., rapamy-
cin), and inhibitors targeting class I PI3K and 1,4,5-inositol 
triphosphate have been explored as potential chemotherapeutic 
agents.4,135,136 Additionally, chloroquine, an anti-malarial drug has 
been reported to prevent the development of lymphoma in mouse 
cancer models by activating autophagy.136
Contrary to its role in the prevention of tumor develop-
ment, it is also argued that autophagy plays a survival role in 
existing tumors because of its ability to cope with the hypoxic 
and nutrient-deprived environments found within tumors.135,137 
Thus, agents used to induce autophagy as a preventative mea-
sure for tumor development may not be desirable in existing 
tumors where autophagy plays a critical role for their survival. 
Both thapsigargin, an ER-stress inducing agent, and rapamy-
cin increased autophagy in multiple myeloma cell lines, while 
autophagic inhibition by 3-MA or beclin-1 siRNA resulted in 
cytotoxic effects and cell death.138 Evodiamine caused a time-
dependent generation of ROS and triggered autophagy in 
human cervix carcinoma HeLa cells, while pre-treatment with 
3-MA decreased cell viability, again indicating that autophagy 
is having a survival role in these cancer cells.139 This complexity 
and dual roles of autophagy in cancer suggests that both agonists 
and inhibitors of autophagy should be considered as potential 
anti-cancer therapies.
Targeting Autophagy as a Therapeutic Strategy 
Against Disease
Since manipulation of autophagic pathways can influence cell 
survival, targeting these pathways is an attractive therapeutic 
strategy against disease. As described in the previous sections, 
function that occurs with aging and this is thought to be a 
major contributor to death of long-lived post-mitotic cells.104 As 
autophagic activity decreases during aging, it is unable to keep 
up with homeostatic maintenance of post-mitotic cells, result-
ing in an overload of ROS and damaged material, ultimately 
leading to cell death.105,106 Mitochondria obtained from ATG7-
deleted skeletal muscle cells displayed defective respiration and 
increased   generation of ROS.107 Aged spleens from senescence-
accelerated prone mice revealed redox imbalance and age-related 
oxidative damage, as well as an upregulation of autophagic path-
ways believed to be a protective response to oxidative stress.108 It 
is also important to note that because autophagy initially plays a 
protective role against moderate oxidative stress, loss of autophagic 
function in aged cells is likely the reason why these cells have a 
lower tolerance to oxidative-induced injury.109
The mechanism responsible for age-associated autophagic 
impairment is unknown, but the inability of lipofuscin-loaded 
secondary lysosomes to fuse with autophagosomes to form the 
autophagolysosome may contribute.4 Suppression of autophagy 
with 3-MA in an aged-cell model lipofuscin-loaded human fibro-
blasts significantly accelerated cell death.101 In addition, aged liver 
cells exhibit an accumulation of autophagosomes whose con-
tents are unable to undergo final lysosomal degradation due to 
this impairment of lysosome/autophagosome fusion.110 Others 
suggest that changes in hormone levels and glucose metabolism 
that occur during aging may also play a role in the impairment 
of autophagy.103,111 Nevertheless, studies on aging in Drosophila, 
nematodes and rodents have shown that activation of autophagy 
likely prevents aging, while autophagic inhibition promotes the 
aging process.15,112,113 This has led to investigators to explore 
potential methods of targeting autophagy to promote cell longev-
ity. Spermidine, a naturally occurring polyamine that declines 
throughout a lifespan, inhibits oxidative stress and necrosis in 
aging yeast, and enhancing autophagy was essential for prevention 
of necrotic cell death.114 Because autophagy is strongly upregu-
lated during periods of cell starvation and nutrient deprivation, 
it is believed that autophagy plays a key role in the anti-aging 
mechanism of caloric-restriction.115 Existing evidence supports 
this theory, as caloric-restriction has been shown to prevent age-
dependent changes in cell membrane and hormone signaling and 
occur with an increase in autophagy.
(4) Autophagy and cancer. The function of autophagy in 
cancer is debatable with data supporting both a survival role and 
cancer suppressive role. Reduced autophagic activity is observed 
in tumor development, suggesting that perhaps autophagy is pri-
marily a mechanism for tumor suppression.116,117 Additionally, 
oxidative stress and ROS-generation have been implicated in the 
pathogenesis of cancer, with cancerous cells generating higher lev-
els of ROS than healthy cells.118-120 ROS accumulation overtime 
has been known to induce somatic mutations, and oxidative stress 
is directly associated with the development of prostate and chronic-
inflammatory bowel disease-related colorectal cancer.63,121,122 The 
human oncosuppressive protein p53 promotes autophagy and 
reduces oxidative stress, suggesting that autophagy is exerting its 
tumor-suppressive actions in part by reducing levels of potentially 
mutagenic ROS.123 Another explanation for tumor-suppression 174  Oxidative Medicine and Cellular Longevity  volume 3 issue 3
Summary
The autophagic process is highly regulated and is stimulated by 
several factors and has a multiplicity of functions. While basal lev-
els of autophagy constantly function to maintain cell   homeostasis 
in virtually every cell type, autophagic activity can be rapidly 
enhanced in response to elevated levels of ROS. However, whether 
this is a pro-survival response or one that contributes ultimately to 
cell death varies in different situations, and depends on the sever-
ity of oxidative stress occurring in a particular pathologic setting. 
Nevertheless, further exploration into the complex and diverse 
roles of ROS-mediated autophagy in different diseases, may reveal   
promising insights into pathogenic mechanisms, leading to novel 
therapeutic developments.
inhibition or activation of autophagy at the genetic level with 
siRNA against essential autophagic genes or overexpression/
constituent activation of these genes respectively, can affect 
cell viability.33,37,74,78,88,92,107,128,138,140-143 Common pharmacologic 
agents including 3-MA (an autophagic inhibitor) and rapamy-
cin (autophagic activator) have been extensively utilized in 
  laboratories to further characterize the role of autophagy in dif-
ferent cell systems.37,63,77,100,101,138,139,144-146 Additionally, the use 
of antioxidants such as NAC have also proved effective in pre-
venting oxidative stress induced autophagy.95 In recent years, the 
development and exploration into novel pharmacologic therapies 
influencing autophagy has generated promising results against dis-
eases.37,72,129-132,136,147-156 Refer to Table 2 for a summary of these 
drugs.
Table 2. Drugs that influence autophagy in disease
Drug Disease Action Reference
everolimus
Atherosclerosis/myocardial 
infarction and pathologic 
cardiac remodeling
induces autophagic cell death of macrophages in atherosclerotic 
 arteries. 
induces autophagy to reduce post-infarct remodeling, cardiac 
  hypertrophy and improve function
147, 148
Sulfaphenazole ischemia/reperfusion injury Cardioprotective enhancement of autophagy 72
rotenone, Trifluoroacetone Cancer
electron transport chain inhibitors that cause rOS-mediated 
  autophagic cell death and tumor suppression
37
Glucose oxidase, Tert-butyl 
hydroperoxide
Cancer Tumor growth suppressed by rOS-mediated autophagy 129, 130
valproic acid Cancer rOS-mediated autophagic cell death and tumor suppression 131
Bortezombin Cancer (breast) inhibits pro-survival of autophagy in cancer cells, resulting in cell death 149
∆9-tetrahydro-cannabinol Cancer
endoplasmic reticulum stress mediates autophagic cell death and 
tumor suppression
132
Chloroquine Cancer (lymphoma) Prevents cancer development by activation of autophagy 136
4-pyridyl-2-anilinothiazole, 
STF-62247
Cancer (renal cell carcinoma) Prevents cancer development by activation of autophagy 150, 151
indol-3-carbinol, genistin Cancer (colon) Prevents cancer development by activation of autophagy 152
resveratrol Aging Alzheimer
Prolongs lifespan by enhancing autophagy/autophagic degradation 
and clearance of amyloid-beta aggregates in neuronal tissue
153, 154
Spermidine Aging Prolongs lifespan by enhancing autophagic cell repair and homeostasis 155
Acipimox Aging Prolongs lifespan by enhancing autophagic cell repair and homeostasis 156
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